March 28, 2019 Par Pharmaceutical, Inc., (as Issuer) and Each of the Guarantors Party hereto and Wells Fargo Bank, National Association (as Trustee) INDENTURE 7.500% Senior Secured Notes due 2027Supplemental Indenture • March 28th, 2019 • Endo International PLC • Pharmaceutical preparations • New York
INDENTURE dated as of March 28, 2019 among PAR PHARMACEUTICAL, INC., a New York corporation (the “Issuer”), the Guarantors (as defined herein) and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association organized under the laws of the United States, as trustee (the “Trustee”).
FIRST AMENDMENTFirst Amendment • March 28th, 2019 • Endo International PLC • Pharmaceutical preparations • New York
FIRST AMENDMENT, dated as of March 28, 2019 (this “Amendment”), to the Credit Agreement, dated as of April 27, 2017 (as the same may be amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”, and as amended by this Amendment, the “Amended Credit Agreement”), by and among Endo International PLC, a company incorporated in the Republic of Ireland (Registered Number 534814) (“Parent”), Endo Luxembourg Finance Company I S.à r.l., a société à responsabilité limitée (private limited liability company) incorporated under the laws of Luxembourg, having its registered office at 12C, rue Guillaume Kroll, L-1882 Luxembourg Grand Duchy of Luxembourg and registered with the Luxembourg Register of Commerce and Companies under number B182645 (the “Lux Borrower”), Endo LLC, a limited liability company organized under the laws of Delaware (the “Co-Borrower”), JPMorgan Chase Bank, N.A. (“JPMorgan”), as Administrative
